| 发明名称 |
PUTRESCINE AND METHOD TO REDUCE RISK OF ANEUPLOID PREGNANCY |
| 摘要 |
A medicament for reducing the risk of having an aneuploid pregnancy in a woman with reduced ovarian ornithine decarboxylase (ODC) activity level, the medicament includes putrescine. A use of putrescine for reducing the risk of having an aneuploid pregnancy in a woman with reduced ovarian ODC activity levels. A method for reducing the risk of having an aneuploid pregnancy in a woman with reduced ovarian ODC activity levels by administering putrescine. |
| 申请公布号 |
US2015224068(A1) |
申请公布日期 |
2015.08.13 |
| 申请号 |
US201314422598 |
申请日期 |
2013.08.21 |
| 申请人 |
Ottawa Hospital Research Institute |
发明人 |
Liu Xingquan Johné;Tao Yong |
| 分类号 |
A61K31/132 |
主分类号 |
A61K31/132 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A medicament for reducing the risk of having an aneuploid pregnancy in a human female with reduced ovarian ornithine decarboxylase (ODC) activity level, the medicament comprising:
putrescine; and a pharmacologically acceptable excipient, diluent or carrier. |
| 地址 |
Ottawa CA |
